Mechanisms involved in the active secretion of CTX-M-15 β-lactamase by pathogenic E. coli ST131
Preprint
Abstract
Infections caused by antimicrobial resistant bacterial pathogens are fast becoming an important global health issue. Strains of Escherichia coli are common causal agents of urinary tract infection and can carry multiple resistance genes. This includes the gene bla CTX-M-15 that encodes for an extended spectrum beta-lactamase (ESBL). While studying antimicrobial resistance (AMR) in the environment we isolated several strains of E. coli ST131 downstream of a WWTP in a local river. These isolates were surviving in the river sediment and characterisation proved that a multi-resistant phenotype was evident. Here, we show that E. coli strain 48 (river isolate ST131), provided a protective effect against a third-generation cephalosporin (cefotaxime) for a susceptible E. coli strain 33 (river isolate ST3576) through secretion of a functional ESBL into the growth medium. Furthermore, extracellular ESBL activity was stable for at least 24 h after secretion. Proteomic and molecular genetic analyses identified CTX-M-15 as the major secreted ESBL responsible for the observed protective effect. In contrast to previous studies, OMVs were not the sole route for CTX-M-15 secretion. Indeed, mutation of the Type I secretion system led to a significant reduction in the growth of the ESBL-producing strain as well as a significantly reduced ability to confer protective effect. We speculate that CTX-M-15 secretion, mediated through active secretion using molecular machinery provides a public goods service by facilitating the survival of otherwise susceptible bacteria in the presence of cefotaxime. Abstract importance: Infections caused by antimicrobial resistant bacterial pathogens have become an important global health issue. Wastewater treatment plants (WWTPs) have been identified as hotspots for the dissemination of antimicrobial resistant genes/bacteria into the environment. In this study, we investigated resistance enzyme secretion by a multi-drug resistant human pathogenic E. coli , isolated from a UK river, downstream of a WWTP. We present evidence that the resistant strain actively secreted an important resistance enzyme into the surrounding medium which degraded the antibiotic cefotaxime. This research provided evidence for the mechanism for secretion of this enzyme which could indicate a new target to tackle antibiotic resistance pathogens.Keywords
All Related Versions
- Published version: Antimicrobial Agents and Chemotherapy, 65 (10), e0066321.
This publication has 46 references indexed in Scilit:
- Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic ResistanceFrontiers in Microbiology, 2012
- Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coliProceedings of the National Academy of Sciences, 2011
- Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest EnglandJournal of Antimicrobial Chemotherapy, 2010
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane VesiclesAnnual Review of Microbiology, 2010
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Mass Spectrometry-Based Label-Free Quantitative ProteomicsJournal of Biomedicine and Biotechnology, 2009
- Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 CloneAntimicrobial Agents and Chemotherapy, 2009
- Roles of Putative Type II Secretion and Type IV Pilus Systems in the Virulence of Uropathogenic Escherichia coliPLOS ONE, 2009
- Origins and virulence mechanisms of uropathogenic Escherichia coliExperimental and Molecular Pathology, 2008
- Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15Emerging Infectious Diseases, 2008